It’s time to reconsider hormone therapy as a treatment for menopause, according to a new study published in the Journal of the American Medical Association. This new review suggests that for women in ...
When preliminary results of the Women's Health Initiative clinical trial were published in 2003, they upended menopause care ...
Mammograms should start at age 40, according to the U.S. Preventive Services Taskforce. And a new study finds hormone therapy ...
A new analysis of a controversial study affirms something menopause experts have long argued: For many women, the benefits of ...
Women who start the menopause before the age of 40 are more likely to die young, new research suggests ...
In the midst of a menopausal moment, where celebrities and society alike are breaking the silence, a new analysis reinforces ...
It's been a big week in women's health news. There is a new recommendation from the U.S. Preventive Services Task Force on what age to start mammograms and an important new study on the use of ...
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, ...
A new analysis of a controversial study affirms something menopause experts have long argued: For many women, the benefits of ...
The global menopause supplement industry is expected to reach $22.7 billion by 2028 Around one third of the entire UK female ...
Veozah (fezolinetant) lowered hot flash frequency and intensity for at least six months in women who couldn’t take hormone ...